Risk Factor Analysis for Developing Metabolic Syndrome in Korean Adults

This study has been completed.
Information provided by (Responsible Party):
Kyung Mook Choi, Korea University
ClinicalTrials.gov Identifier:
First received: April 28, 2012
Last updated: October 12, 2015
Last verified: April 2014
In Asia, the prevalence of metabolic syndrome have been dramatically increased. Therefore, the investigators intend to the collect the blood sample, laboratory, anthropometric, and body composition parameters prospectively to examine the risk factors of metabolic syndrome. Furthermore, the investigators will collect the data of carotid IMT and branchial ankle pulse wave velocity to clarify the metabolic risk factors of atherosclerosis.

Metabolic Syndrome, Atherosclerosis

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Korea University:

Primary Outcome Measures:
  • The impact of various cardiovascular risk factors (inflammatory markers, hepatokines, adipokines, body composition parameters) for developing metabolic syndrome in prospective design [ Time Frame: 36months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • The relationship of various cardiovascular risk factors (inflammatory markers, hepatokines, adipokines, body composition parameters) with metabolic syndrome and atherosclerosis measured by baPWV and carotid IMT in cross sectional design [ Time Frame: 36months ] [ Designated as safety issue: No ]

Enrollment: 1800
Study Start Date: February 2012
Study Completion Date: May 2015
Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)
Apparently Health People


Ages Eligible for Study:   20 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Apparently healthy people who underwent medical routine check up in Korea University Helath Promotion Center.

Inclusion Criteria:

  • Apparently healthy people who underwent medical routine check up in Korea Health Promotion Center.
  • age > 20 years

Exclusion Criteria:

  • History of cardiovascular disease (myocardial infarction, unstable angina, stroke, or cardiovascular revascularization)
  • Stage 2 hypertension
  • Severe renal or hepatic disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01594710

Korea, Republic of
Korea University Guro Hospital
Seoul, Korea, Republic of
Sponsors and Collaborators
Korea University
  More Information

No publications provided by Korea University

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Kyung Mook Choi, Professor, Korea University
ClinicalTrials.gov Identifier: NCT01594710     History of Changes
Other Study ID Numbers: KoreaHealth_MS 
Study First Received: April 28, 2012
Last Updated: October 12, 2015
Health Authority: South Korea: Institutional Review Board

Additional relevant MeSH terms:
Metabolic Syndrome X
Arterial Occlusive Diseases
Cardiovascular Diseases
Glucose Metabolism Disorders
Insulin Resistance
Metabolic Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on February 11, 2016